3:30pm to 5:20pm
Room HSB T639
Wednesday October 12: Martha
Feldman, President and Chief Executive Officer, Drug & Device
Development Co., Inc. (DDD) will lecture on Medical Device Regulation. Feldman assists companies in bringing drugs
and devices through the development process to market. Her expertise is in developing and
implementing regulatory and clinical strategies, and in troubleshooting
regulatory impediments and clinical trial activities. Read more….
Friday October 14:
Gordon Brandt will lecture on
Medical Device Regulation with an emphasis on Clinical trials. Gordon Brandt has led the clinical and
regulatory development of drugs and devices at a number of Seattle-area
biotechnology companies and has conducted clinical trials in the US, Europe,
and Asia.
